Schizophrenia Test (Symptoms & Assessment Guide)

The schizophrenia test is a clinician-led assessment, not a self-report quiz: a psychiatric evaluation against DSM-5-TR criteria ^[1]. Diagnosis follows those criteria; severity and change are rated on clinician-administered scales, most often the Brief Psychiatric Rating Scale (BPRS) with the Clinical Global Impression severity rating (CGI-S) alongside it.

If you or someone you know is experiencing psychotic symptoms, seek a psychiatric evaluation promptly. In a crisis, call or text 988 (Suicide Crisis Helpline in Canada; Suicide & Crisis Lifeline in the US) or go to the nearest emergency department.

What does the schizophrenia assessment measure?

A schizophrenia assessment looks at three groups of symptoms:

• Positive symptoms: hallucinations, delusions, disorganized thinking or speech, and grossly disorganized or catatonic behaviour.
• Negative symptoms: diminished emotional expression and avolition (reduced motivation), along with related features such as reduced speech and social withdrawal.
• Cognitive difficulties: problems with attention, memory and other thinking skills.

It also establishes how long symptoms have lasted, how much they affect work, relationships and self-care, and whether another condition better explains them.

DSM-5-TR criteria for schizophrenia. Criteria A through E must all be met ^[1]:

• Symptoms (A). Two or more of delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behaviour, and negative symptoms, each present for a significant portion of a one-month period (less if successfully treated). At least one must be delusions, hallucinations or disorganized speech.
• Functioning. Functioning is markedly below the prior level.
• Duration. Continuous signs of disturbance last at least six months.
• Exclusions. Schizoaffective and mood disorders, substances and other medical conditions are ruled out.

How do you give the schizophrenia assessment?

1. Psychiatric interview: symptom history, onset and duration, functioning, substance use, medical history and family history, with collateral information from family where possible.
2. Medical work-up: to rule out substance-induced psychosis and psychosis due to another medical condition.
3. Diagnosis against DSM-5-TR: placing the presentation on the schizophrenia spectrum (see the table below).
4. Baseline severity ratings: the BPRS (18 items, each rated 1 = not present to 7 = extremely severe after interview and observation) and the CGI-S (a single 1-7 rating of overall illness severity, from "normal, not at all ill" to "among the most extremely ill patients").
5. Repeat ratings: re-rate the BPRS and CGI-S at clinical intervals to track response.

Both scales are clinician-rated; clients do not complete them.

How do you score and interpret the schizophrenia assessment?

There is no single schizophrenia score and no cutoff that diagnoses it. Diagnosis is a clinical judgement against DSM-5-TR criteria. The scales describe severity and change:

• BPRS total: 18 to 126. Overall and Gorham did not publish severity cutoffs. In a linking study of 1,979 acutely ill adults with schizophrenia from seven drug trials ^[3], a BPRS total of about 31 corresponded to "mildly ill" on the CGI, 41 to "moderately ill" and 53 to "markedly ill".
• Change from baseline: in the same study, a CGI rating of "minimally improved" corresponded to BPRS reductions of 24, 27 and 30% at weeks 1, 2 and 4, and "much improved" to reductions of 44, 53 and 58% ^[3].
• CGI-S: read the anchor label directly (see the CGI page). Recording it alongside the BPRS checks that a change in score is clinically visible.

These links were derived in acutely ill adults with positive symptoms and may not transfer to other groups.

Psychometric properties

This page describes an assessment process, so psychometrics belong to the scales used within it.

• BPRS. Its clinical meaning has been anchored to CGI ratings by equipercentile linking in 1,979 trial participants ^[3]; see the BPRS page for reliability evidence.
• CGI. It was developed by Guy in 1976 for NIMH-sponsored trials. A review of its clinical use describes the severity and improvement scales as a readily understood, practical measure that a clinician can apply in busy practice ^[4].

Limitations

• No questionnaire or online test can diagnose schizophrenia.
• The BPRS and CGI-S depend on rater training and judgement.
• Severity anchors come from trials in acutely ill adults and may not fit first-episode, chronic or outpatient groups.
• Symptoms overlap with mood disorders with psychotic features, substance-induced psychosis and medical causes, which must be ruled out.

Schizophrenia spectrum disorders

The spectrum is defined mainly by how long active psychotic symptoms last and whether a mood episode is present ^[1].

Each diagnosis requires that substance or medication effects and other medical conditions have been ruled out.

Why early assessment matters

A longer duration of untreated psychosis is associated with poorer treatment response, symptom control and functional outcome ^[5].

The NIMH RAISE Early Treatment Program followed 404 people with first-episode psychosis in 34 US clinics for at least two years ^[6]:

• Team-based care. Those receiving NAVIGATE, a team-based coordinated specialty care model, stayed in treatment longer and improved more in quality of life and symptoms than those in usual community care.
• Earlier is better. Gains were larger when untreated psychosis was shorter than the median of 74 weeks.